Suchergebnisse - "Douxfils, Jonathan"

PubPharm (7)

1

The DaXa-inhibition assay : A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs

enthalten in: Thrombosis research | 2018

von van Pelt, L. | Lukens, M. | Testa, S. | +3

2

Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels

enthalten in: Thrombosis research | 2017

von Sabor, L. | Raphaël, M. | Dogné, J. | +2

3

Impact of the Direct Oral Anticoagulants on Activated Clotting Time

enthalten in: Journal of cardiothoracic and vascular anesthesia | 2017

von Dincq, A. | Lessire, S. | Chatelain, B. | +4

4

Periprocedural Management of Direct Oral Anticoagulants Should Be Guided by Accurate Laboratory Tests

enthalten in: Regional anesthesia and pain medicine | 2016

von Lessire, S. | Douxfils, J. | Dincq, A. | +1

CommentOn: Reg Anesth Pain Med. 2016 Mar-Apr;41(2):127-9. - PMID 26882272

5

Which method of renal function evaluation is best appropriate in patients with direct oral anticoagulants?

enthalten in: Annales de biologie clinique | 2015

von Gouin-Thibault, I. | Larock, A. | Douxfils, J. | +1

6

Is Thrombin Time useful for the assessment of dabigatran concentrations? An in vitro and ex vivo study

enthalten in: Thrombosis research | 2015

von Lessire, S. | Douxfils, J. | Baudar, J. | +6

7

Criteria for prescribing dabigatrin extexilate and rivaroxaban really appropriate? Authors' reply

enthalten in: The Annals of pharmacotherapy | 2015

von Larock, A. | Mullier, F. | Douxfils, J. | +2

CommentOn: Ann Pharmacother. 2014 Oct;48(10):1258-68. - PMID 24982310

1
[1]